
Thomas Celona
Associate Editor at Cancer Today
Associate Editor, @CancerTodayMag. Views expressed are my own.
Articles
-
2 weeks ago |
cancertodaymag.org | Thomas Celona
CANCER VACCINATION offers the promise of training the body’s immune system to identify and attack cancer cells from within. While this technology is one of the most exciting topics in cancer research, many investigational vaccines have not been effective in human trials. But in the past decade, researchers have learned more about immunology, identified new targets and developed novel technologies, fueling optimism about this approach, according to Darrell J.
-
2 weeks ago |
cancertodaymag.org | Thomas Celona
ADDING IMMUNOTHERAPY to standard care can help reduce recurrence risk for people with locally advanced head and neck cancers, according to a presented April 27 at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago. (The AACR publishes Cancer Today.)People diagnosed with head and neck cancer typically undergo surgery to remove the tumor, followed by radiation and, in some cases, chemotherapy to reduce their risk of the cancer returning.
-
2 weeks ago |
cancertodaymag.org | Thomas Celona
SURGERY TO REMOVE a tumor is a common part of cancer care. The procedure can rid the body of the disease, but it comes with a host of potential risks and life-changing side effects. For example, people who have their stomach or esophagus removed face difficulty eating, and people who have surgery for rectal cancer often need a permanent colostomy bag.
-
2 weeks ago |
cancertodaymag.org | Thomas Celona
A MEDICATED GEL can help treat a skin problem that is a common side effect of colorectal cancer treatment, according to a presented April 27 at the American Association for Cancer Research (AACR) Annual Meeting 2025 in Chicago. (The AACR publishes Cancer Today.)Research estimates 60% to 80% of colorectal tumors overexpress the EGFR protein, which promotes cell growth. An overabundance of this protein can cause cancer to spread and can increase the risk for recurrence and death.
-
3 weeks ago |
cancertodaymag.org | Thomas Celona
Every week, the editors of Cancer Today magazine bring you the top news for cancer patients from around the internet. Stay up to date with the latest in cancer research and care by subscribing to our e-newsletter.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 937
- Tweets
- 4K
- DMs Open
- No

RT @CancerTodayMag: Results of a clinical trial presented at the @AACR Annual Meeting 2025 show a topical gel can ease a rash that is a com…

RT @CancerTodayMag: Read our spring issue with stories covering the growing role of liquid biopsies, a possible treatment for cancer cachex…

RT @CancerTodayMag: The rate of precancerous cervical lesions in young women has declined since the introduction of HPV vaccines, the FDA a…